North America Non-invasive Aesthetic Treatment Market Size, Share & Trends Analysis Report By Procedure (Skin Rejuvenation, Injectable), By End Use (Hospital, Traditional Spa, HCP Owned Clinic), And Segment Forecasts, 2021 - 2028

Report Overview

The North America non-invasive aesthetic treatment market size to be valued at USD 46.07 billion by 2028 and is expected to grow at a compound annual growth rate (CAGR) of 13.2% during the forecast period. The demand for non-invasive procedures has witnessed a drastic increase over the decade as they offer advantages including smaller incisions, shorter hospital stays, rapid wound healing, lesser pain, fewer surgical wounds, and lower risk of complications as compared to invasive surgeries. Moreover, the effectiveness and safety provided by current minimally invasive treatments are also supporting market growth.

However, the advent of the COVID-19 pandemic has hugely affected the overall market for non-invasive aesthetic treatment in North America. But many aesthetic professionals believe that pandemics might most likely propel the overall aesthetic market. Many dermatology clinics have witnessed a boost in the number of future appointments and consultations for different skin treatments and this is expected to contribute to market growth.

According to the American Society of Plastic Surgery, the pandemic led to an increase in the acceptance of cosmetic procedures. The association’s survey of more than 1,000 women reported that 11% of the women are now more inclined and interested in surgical or nonsurgical procedures as before COVID-19. More than 35% of women that previously underwent at least one aesthetic procedure planned to spend more on procedures in 2021 than in 2020.

The advent of the COVID-19 pandemic had affected the overall aesthetic and dermatology market. According to SKIN - The Journal of Cutaneous Medicine, there was a decline of more than 50% inpatient volume for aesthetic procedures in the U.S. in 2020. According to Allure, restarting laser-related was slow during and after the pandemic due to safety concerns & infection control. However, many countries have allowed resuming of dermatology and aesthetic clinics under strict Covid-19 protocols, and this is likely to assist the market to plunge back to pre-pandemic levels. Various factors such as a considerable increase in video calls and the benefit of discreet recovery at home are boosting the post-pandemic market.

According to an article published by the American Society of Plastic Surgeons, the number of minimally invasive & surgical cosmetic procedures increased by nearly 1%, from 2018 to 2019. Around 13,281,235 non-invasive aesthetic procedures were performed in the country in 2020 and botulinum toxin fillers, cellulite treatment, chemical peel, IPL treatment, & laser hair removal were the top five procedures.

This can be attributed to factors such as technological advancements, relatively higher disposable income, and the availability of a number of aesthetic professionals in the country. Furthermore, The U.S. is among the most favored market for aesthetic companies for new product launches. For instance, in June 2020, Cynosure launched its Elite iQ platform which is made for customized permanent laser hair removal treatments for all skin types in U.S., Europe, and Australia.

The increasing geriatric population in the U.S and Canada is expected to further boost the market growth. Signs of aging such as wrinkles, lack of skin elasticity, and dark spots start appearing between 25 and 30 years of age and become more prominent from 30 to 65 years of age. These above-mentioned factors are expected to propel the growth of the market for non-invasive aesthetic treatment in North America.

North America Non-invasive Aesthetic Treatment Market Trends

Less recovery time, no scarring, low cost, and fewer complications are driving the non-invasive aesthetic treatment market. Additionally, it has been demonstrated that open surgeries have a lower accuracy rate than minimally invasive surgical procedures.

Younger generations have been attracted to laser treatments and their benefits for treating skin conditions, modifying body parts, and restoring posture. The government programs are assisting in improving public knowledge of non-invasive aesthetic procedures and promoting the market's expansion. As a result, the demand for non-invasive aesthetic treatments in North America is expanding with the growing acceptance of these operations treatments.

Additionally, the COVID-19 pandemic is confusing medical facilities in the area with previously entirely unknown clinical and operational challenges with diagnoses and bed availability. Moreover, a reduction in non-invasive cosmetic treatments has been associated with high priority for the diagnosis and treatment of COVID-19, restricting the growth of the North American non-invasive aesthetic treatment market.

The availability of technologically advanced & user-friendly products is expanding benefits in the form of minimally invasive surgeries over traditional surgery. Including quicker recovery, decreased pain, shorter hospital stays, and higher efficiency rates are creating lucrative growth opportunities for the North America non-invasive aesthetic treatment market.

Procedure Insights

In 2020, the injectable segment dominated the market for non-invasive aesthetic treatment in North America and held the largest revenue share of 54.0% in 2020. The segment is expected to show the highest CAGR over the forecast period. This is mainly because there is a wide application of injectable in aesthetic treatment. Also, dermal injections are effective, show the immediate result, have high patient satisfaction and low recovery period attributing to the high segment growth. Besides, as per the American Society of Dermatology Surgery, the injectable is the most performed procedure in the U.S. It also revealed that filler treatments witnessed an increase of 78% over the course of 8 years in the U.S.

The skin rejuvenation segment held a revenue share of 30.4% in 2020 owing to the advancement in procedures like photo rejuvenation, deep chemical peel, and laser resurfacing. The chemical peels of skin rejuvenation segment, held the highest market share in 2020, as it helps treat skin damage, acne scars, discoloration, hyperpigmentation, and wrinkles. However, the others segment which includes hair removal, non-surgical fat reduction, sclerotherapy, cellulite treatment is expected to show significant growth over the forecast period.

End-use Insights

The MedSpa segment dominated the market for non-invasive aesthetic treatment in North America and held the highest revenue share of 34.2% in 2020. A Medspa is a facility where cosmetic services are provided under the supervision of a licensed physician. They are also known as cosmetic clinics or esthetic centers. Med spas are generally a combination of aesthetic medical centers and day spas that offer corrective medical skincare treatments and products. These facilities follow all the regulatory policies and standards set by the government.

Medspas are increasingly adopting novel treatment systems to cater to a wider esthetic need of patients. The employees in Medspa need to have a license in esthetics as well as a medical education. In 2017, the American Med Spa Association (AmSpa) reported that more than 4,200 Medspas are operating in the U.S. and this number has increased by 50% since 2016. Factors such as membership subscriptions, service marketing, adoption of novel laser technologies, and cost-effective treatments are expected to significantly boost the med spa segment.

Regional Insights 

The U.S dominated the market for non-invasive aesthetic treatment in North America and accounted for the largest revenue share of 85.0% in 2020. The segment is expected to showcase a significant CAGR over the forecast period. This is attributed to the strong medical infrastructure, well-established reimbursement policies, the existence of key market players, and the high adoption of novel aesthetic procedures. Moreover, attributes like high acceptance and openness towards aesthetic treatments, and soaring appearance-conscious customer pool is likely to propel market growth.

Canada is also witnessing growth in the non-invasive aesthetic treatment especially for the injectable segment largely due to the fact that nearly one in every five women in Canada is dissatisfied with her appearance. High healthcare expenditure and the presence of advanced healthcare facilities are some of the key factors fueling the growth of the market for non-invasive aesthetic treatment in Canada.

Key Companies & Market Share Insights

Primary parameters affecting the competitive nature include rapid adoption of new technologies by cosmetic and medical clinics, expansion of services in different parts of the country, and increase in patient footfall through discounts and marketing services. For instance, in April 2019, ANEWSKIN LLC expanded its esthetic services by opening a new Aesthetic Clinic and Medical Spa downtown DC, just blocks away from the White House. This new location might increase the footfall of patients wanting to opt for esthetic treatments, thereby generating high revenue. Some of the prominent players in the North America non-invasive aesthetic treatment market include:

• Toronto Cosmetic Clinic (TCC)

• The Cosmetic Clinic

• Skinovative of Gilbert-Medical Spa

• Shea Aesthetic Clinic

• Chapter Aesthetic Studio

• AnewSkin Medspa

• The Ottawa Skin Clinic

• Manhattan Aesthetics

• Toronto Medical Aesthetics

• Dr. Cory Torgerson

• Canada MedLaser, Inc

• SkinRhümMD

• Skin Vitality Medical Clinic

• True MediSpa; Dermapure

North America Non-invasive Aesthetic Treatment Market Report Scope

North America Non-invasive Aesthetic Treatment Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the North America non-invasive aesthetic treatment market report on the basis of procedure, end-use, and region:

• Procedure Outlook (Revenue, USD Million, 2016 - 2028)

  • Injectables

    • Botulinum Toxin

    • Calcium Hydroxylapatite

    • Hyaluronic Acid

    • Polymer Filler

    • Collagen

  • Skin Rejuvenation

    • Chemical Peel

    • Laser Skin Resurfacing

    • Photorejuvenation

  • Others

    • Hair Removal

    • Nonsurgical Fat Reduction

    • Sclerotherapy

    • Cellulite Treatment

• End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospital/Surgery Center

  • Medspa

  • Traditional Spa

  • HCP owned clinic

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada